Blood-Based Biomarkers for Early Alzheimer’s Disease Diagnosis

Watch Michael Schöll, Professor at the University of Gothenburg and Principal Research Fellow at University College London, discuss blood-based biomarkers for early Alzheimer’s diagnosis presented at EAN 2024. He outlines the REAL AD study, which aims to validate a realistic screening approach for early Alzheimer’s using digital and blood-based biomarkers and its potential to improve Alzheimer’s diagnostics in primary care.